In cancer cells, HIF-1α increases Programmed death-ligand 1 (PD-L1) expression and cytokines secretion (i.e., VEGF) thereby promoting tumor associated macrophages (TAM) accumulation and immune escape. Here, HIF1A is linked to cancer.